UnitedHealth Group (UNH) Expected to Post Quarterly Earnings on Tuesday

UnitedHealth Group (NYSE:UNH) is projected to issue its Q3 2026 results before the market opens on Tuesday, October 13th. Analysts expect the company to post earnings of $4.14 per share and revenue of $111.31 billion for the quarter. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, October 13, 2026 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same quarter in the prior year, the company earned $4.08 earnings per share. The business’s revenue was up .4% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $19.85 EPS for the current fiscal year and $22.54 EPS for the next fiscal year.

UnitedHealth Group Price Performance

UNH stock opened at $378.82 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The firm has a 50 day moving average price of $388.78 and a 200-day moving average price of $381.06. UnitedHealth Group has a 52-week low of $255.96 and a 52-week high of $461.62. The firm has a market capitalization of $340.03 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 1.43 and a beta of 0.60.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $512.00 price objective (up from $492.00) on shares of UnitedHealth Group in a research report on Wednesday, September 2nd. Mizuho boosted their target price on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. Piper Sandler raised their price target on UnitedHealth Group from $477.00 to $499.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Raymond James Financial lifted their price target on UnitedHealth Group from $370.00 to $460.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Finally, JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $462.59.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts view UnitedHealth’s diversified healthcare platform, improving Medicare Advantage profitability and lower valuation as advantages over Humana. The stock’s reduced earnings multiple could provide room for a re-rating if the turnaround continues. UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
• Positive Sentiment: UnitedHealth’s third-quarter earnings are expected to rise sharply year over year, with consensus estimates near $4.12–$4.15 per share on approximately $111.4 billion in revenue. Investors are watching for cost controls, restructuring benefits and a possible increase in 2026 guidance. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: One investment thesis argues that UnitedHealth’s deliberate exit from unprofitable businesses is driving meaningful margin expansion despite flat revenue and lower membership. At roughly 16 times projected 2027 earnings, the shares trade below their historical average, leaving potential upside if margin gains prove durable. UnitedHealth: A Beat Is Priced In, But There’s Room For Surprise
• Neutral Sentiment: Medicare Advantage star-rating changes are reshuffling the competitive landscape. Humana benefited substantially from improved ratings, while UnitedHealth was described as holding steady; the revised methodology may affect reimbursement and enrollment trends without necessarily reflecting changes in care quality. Humana Soars on Improved Medicare Advantage Star Ratings
• Negative Sentiment: TD Cowen lowered its price target for UnitedHealth to $402, reflecting continued caution around margin repair, medical costs and subdued revenue growth. The upcoming earnings report remains an important test of management’s recovery plan. UnitedHealth Group Price Target Lowered

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.